Evidence map›Paper›PMID 39358867›Full record

ArticleJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics2024

Detection of Residual iPSCs Following Differentiation of iPSC-Derived Retinal Pigment Epithelial Cells.

Matthew Hill, Cynthia Andrews-Pfannkoch, Evan Atherton, Travis Knudsen, Emma Trncic, Alan D Marmorstein

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matthew HillDepartment of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.
Cynthia Andrews-PfannkochDepartment of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.
Evan AthertonDepartment of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.
Travis KnudsenDepartment of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.
Emma TrncicDepartment of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.
Alan D MarmorsteinDepartment of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.

Funding

Preclinical testing of iPSC derived retinal pigment epithelium to treat macular degenerationU01EY030547 · NEI · MAYO CLINIC ROCHESTER · PI MARMORSTEIN, ALAN D · 2019 to 2019
$398k
NEI NIH HHS U01 EY030547
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell DifferentiationInduced Pluripotent Stem CellsRetinal Pigment EpitheliumCells, CulturedEpithelial CellsHumansReal-Time Polymerase Chain ReactionRNA-Binding ProteinsLin28A protein, humanRNA-Binding ProteinscGMPgene expressioninduced pluripotent stem cellmacular degenerationretinal pigment epithelium

Identifiers

PMID39358867
PMCPMC11698679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.